Geriatric Unit, Department of Palliative Medicine, Poznan University of Medical Sciences, 61-245 Poznan, Poland.
Department of Occupational Therapy, Poznan University of Medical Sciences, 60-781 Poznan, Poland.
Int J Environ Res Public Health. 2022 Jan 18;19(3):1030. doi: 10.3390/ijerph19031030.
Polypharmacy is a challenging issue in geriatrics. The aim of the study was to characterize correlates of polypharmacy in the PolSenior project. The PolSenior project, was a comprehensive survey in a large and longitudinal representative sample of thePolish older population. The project was conducted by the International Institute of Molecular and Cell Biology in Warsaw between 2008 and 2011. All medications consumed during the week preceding the survey were evaluated for each participant (n = 4793, including 2314 females (48.3%)). Thereafter, the percentage of those with polypharmacy (at least 5 medications) and excessive polypharmacy (at least 10 medications) was calculated, and their correlates were determined. The average number of medications used by participants was 5.1 ± 3.6, and was higher in females than in males (5.5 ± 3.5 vs. 4.8 ± 3.5; < 0.001). Polypharmacy characterized 2650 participants (55.3%) and excessive polypharmacy-532 of them (11.1%). The independent correlates associated withpolypharmacy were: age over 70 years, female sex, higher than primary education, living in an urban area, comorbidities, any hospitalization during past five years, and visiting general practicioners at least yearly. As for correlates with excessive polypharmacy, they were: age 80-84 years, female sex, living in an urban area, diagnosis of at least four chronic diseases, and at least two hospitalizations in the last five years. This study serves as a starting place to understand patient characteristics associated with polypharmacy, excessive polypharmacy, and identify targeted interventions.
多药治疗是老年医学中的一个难题。本研究旨在描述 PolSenior 项目中多药治疗的相关因素。PolSenior 项目是 2008 年至 2011 年期间在华沙的国际分子与细胞生物学研究所对波兰老年人群进行的一项全面调查,该研究采用了一个具有代表性的大样本进行纵向研究。该研究对每个参与者(n = 4793,包括 2314 名女性(48.3%))在调查前一周内服用的所有药物进行了评估。然后,计算了多药治疗(至少使用 5 种药物)和过度多药治疗(至少使用 10 种药物)的比例,并确定了其相关因素。参与者平均使用的药物数量为 5.1 ± 3.6,女性高于男性(5.5 ± 3.5 比 4.8 ± 3.5;<0.001)。2650 名参与者(55.3%)患有多药治疗,532 名参与者(11.1%)患有过度多药治疗。与多药治疗相关的独立相关因素包括:年龄大于 70 岁、女性、高于小学教育程度、居住在城市地区、合并症、过去五年内的任何住院治疗以及每年至少一次就诊于全科医生。而与过度多药治疗相关的因素是:年龄 80-84 岁、女性、居住在城市地区、至少诊断出四种慢性疾病以及过去五年内至少两次住院治疗。本研究为理解与多药治疗、过度多药治疗相关的患者特征并确定有针对性的干预措施提供了基础。